Median Technologies (XPAR:ALMDT) Other Current Liabilities: €38.91 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALMDT Median Technologies XPAR:ALMDT
49 GF Score
Price €4.14
GF Value €1.71
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Median Technologies Other Current Liabilities?

Median Technologies XPAR:ALMDT +2.35% 49 Other Current Liabilities is €38.91 Mil as of Dec. 2025. GuruFocus rates XPAR:ALMDT with a GF Score™ of 49/100 and a GF Value™ of €1.71 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Median Technologies's other current liabilities for the quarter that ended in Dec. 2025 was €38.91 Mil.

Median Technologies's quarterly other current liabilities declined from Dec. 2024 (€18.76 Mil) to Jun. 2025 (€16.23 Mil) but then increased from Jun. 2025 (€16.23 Mil) to Dec. 2025 (€38.91 Mil).

Median Technologies's annual other current liabilities increased from Dec. 2023 (€17.24 Mil) to Dec. 2024 (€18.76 Mil) and increased from Dec. 2024 (€18.76 Mil) to Dec. 2025 (€38.91 Mil).

Median Technologies Other Current Liabilities Related Terms

Median Technologies Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Median Technologies's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Median Technologies Other Current Liabilities Chart

Median Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.17 18.58 17.24 18.76 38.91

Median Technologies Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.24 15.07 18.76 16.23 38.91
XPAR:ALMDT
49GF Score
Median Technologies XPAR:ALMDT
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Median Technologies Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €38.91 Mil mean?
Median Technologies (XPAR:ALMDT) has a Other Current Liabilities of €38.91 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Median Technologies.
Is Median Technologies' Other Current Liabilities too high?
Median Technologies' current Other Current Liabilities is €38.91 Mil. Overall, Median Technologies has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Median Technologies' Other Current Liabilities compare to ABT and SYK?
Median Technologies' Other Current Liabilities of €38.91 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Median Technologies. Median Technologies's current Other Current Liabilities is €38.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Median Technologies stock overvalued right now?
Based on GuruFocus' analysis, Median Technologies (XPAR:ALMDT) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.71, compared to a current price of €4.14 — trading 141.8% above its estimated fair value. The current Other Current Liabilities is €38.91 Mil. Median Technologies' overall GF Score™ is 49/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Median Technologies (XPAR:ALMDT), the current Other Current Liabilities is €38.91 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Median Technologies (XPAR:ALMDT) Overvalued in 2026?

Based on GuruFocus' analysis, Median Technologies stock appears to be overvalued. The current stock price of €4.14 is trading 141.8% above its estimated GF Value™ of €1.71. GuruFocus considers Median Technologies to be Significantly Overvalued.

Key valuation signals for XPAR:ALMDT:

  • Other Current Liabilities: €38.91 Mil
  • GF Value™: €1.71 vs. price of €4.14 (141.8% above fair value)
  • GF Score™: 49/100 with 8 warning signs

No single metric tells the full story. See the XPAR:ALMDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Median Technologies Business Description

Other Exchanges 4ZG:Germany
Address 1800 Route Des Cretes, Les Deux Arcs, Building B, Valbonne, FRA, 06560
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
49GF Score

Get the complete analysis for XPAR:ALMDT

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.14
Price
€1.71
GF Value